RxDoctor Payments Data

Gopal Patel, MD

Dermatology · Media, PANPI 1376774570

Payments from drug & device makers

$799in general payments, 2019–2025

Across 42 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$196
  • Novartis$151
  • Johnson & Johnson$117
  • Galderma Laboratories, L.p.$50
  • Sun Pharmaceutical Industries Inc.$43
  • Pfizer$40
  • plus $203 from 7 others

What the payments were for

  • Food & beverage$78698%
  • Education$132%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie9$196
Novartis8$151
Johnson & Johnson5$117
Galderma Laboratories, L.p.3$50
Sun Pharmaceutical Industries Inc.2$43
Pfizer3$40
Lilly USA, LLC2$35
Amgen2$34
Sanofi2$34
Strata Skin Sciences, Inc.2$32
Prugen, Inc. Pharmaceuticals2$27
Bristol Myers Squibb1$25
Journey Medical Corporation1$16

How this compares

$799 in reported general payments places this provider in the 35th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$393,015
Medicare patients
1,023
Services billed
5,688

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab14$102,063
Dupixent PenDupilumab13$50,993
Clobetasol Propionate144$5,365
Ketoconazole238$3,824
Tacrolimus25$2,906
Fluorouracil32$1,901
Tretinoin12$1,834
Azelaic Acid13$1,153
Fluocinonide38$1,031
Metronidazole22$1,011
Triamcinolone Acetonide110$952
Doxycycline Hyclate41$943
Hydrocortisone96$794
Desonide14$750
Betamethasone Dipropionate18$712

Paid to pharmacies, not to this prescriber.

Other dermatology in Media

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →